These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 26884860)
1. Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients. Xu P; Zhao M; Liu Z; Liu Y; Chen Y; Luo R; Fang W Int J Clin Exp Pathol; 2015; 8(12):15887-94. PubMed ID: 26884860 [TBL] [Abstract][Full Text] [Related]
2. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas. Zhan P; Shen XK; Qian Q; Wang Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK Oncol Rep; 2012 Apr; 27(4):1072-8. PubMed ID: 22200856 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival. He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781 [TBL] [Abstract][Full Text] [Related]
4. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma. Guo T; Zhao S; Li Z; Li F; Li J; Gu C Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522 [TBL] [Abstract][Full Text] [Related]
5. Analysis of MAT3 gene expression in NSCLC. Zheng S; Du Y; Chu H; Chen X; Li P; Wang Y; Ma Y; Wang H; Zang W; Zhang G; Zhao G Diagn Pathol; 2013 Oct; 8():166. PubMed ID: 24107548 [TBL] [Abstract][Full Text] [Related]
6. Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma. Zhong Y; Jiang L; Lin H; Li B; Lan J; Liang S; Shen B; Lei Z; Zheng W Diagn Pathol; 2015 Jul; 10():101. PubMed ID: 26168791 [TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 90-β over-expression is associated with poor survival in stage I lung adenocarcinoma patients. Wu Y; Huang B; Liu Q; Liu Y Int J Clin Exp Pathol; 2015; 8(7):8252-9. PubMed ID: 26339394 [TBL] [Abstract][Full Text] [Related]
8. Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma. Wang J; Shen H; Fu G; Zhao D; Wang W Oncotarget; 2017 Feb; 8(6):9442-9450. PubMed ID: 28038462 [TBL] [Abstract][Full Text] [Related]
9. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma. Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of decreased GRK6 expression in lung adenocarcinoma. Yao S; Zhong L; Liu J; Feng J; Bian T; Zhang Q; Chen J; Lv X; Chen J; Liu Y J Cancer Res Clin Oncol; 2016 Dec; 142(12):2541-2549. PubMed ID: 27601164 [TBL] [Abstract][Full Text] [Related]
11. CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response. Seiler R; Thalmann GN; Rotzer D; Perren A; Fleischmann A Mod Pathol; 2014 Jan; 27(1):87-95. PubMed ID: 23887292 [TBL] [Abstract][Full Text] [Related]
12. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status. Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125 [TBL] [Abstract][Full Text] [Related]
13. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma. Zhang J; Sun G; Mei X Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212 [TBL] [Abstract][Full Text] [Related]
14. Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma. Sholl LM; Barletta JA; Yeap BY; Chirieac LR; Hornick JL Am J Surg Pathol; 2010 Aug; 34(8):1193-8. PubMed ID: 20631605 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of differential CCND1 expression in patients with resected gastric adenocarcinoma. Ma L; Wang X; Lan F; Yu Y; Ouyang X; Liu W; Xie F; Huang Q Med Oncol; 2015 Jan; 32(1):338. PubMed ID: 25452171 [TBL] [Abstract][Full Text] [Related]
16. High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis. Thomas A; Chen Y; Steinberg SM; Luo J; Pack S; Raffeld M; Abdullaev Z; Alewine C; Rajan A; Giaccone G; Pastan I; Miettinen M; Hassan R Oncotarget; 2015 May; 6(13):11694-703. PubMed ID: 26028668 [TBL] [Abstract][Full Text] [Related]
17. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer. Liu J; Ping W; Zu Y; Sun W Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249 [TBL] [Abstract][Full Text] [Related]
18. Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma. Saito H; Yamashita M; Ogasawara M; Yamada N; Niisato M; Tomoyasu M; Deguchi H; Tanita T; Ishida K; Sugai T; Yamauchi K Hum Pathol; 2016 Apr; 50():1-10. PubMed ID: 26997432 [TBL] [Abstract][Full Text] [Related]
19. SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer. Azuma Y; Yokobori T; Mogi A; Altan B; Yajima T; Kosaka T; Onozato R; Yamaki E; Asao T; Nishiyama M; Kuwano H J Surg Oncol; 2015 Aug; 112(2):231-7. PubMed ID: 26180037 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of Musashi-1 in endometrioid adenocarcinoma. Ma L; Xu YL; Ding WJ; Shao HF; Teng YC Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]